Cardioprotective effect of licochalcone D against myocardial ischemia/reperfusion injury in langendorff-perfused rat hearts

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Yuan, Xuan ^a   Niu, Hai Tao ^a   Wang, Peng Long ^c   Lu, Jie ^a   Zhao, Hong ^c   Liu, Shi Han ^a   Zheng, Qiusheng ^b,c   Li, Chang Gui ^a  

^a QINGDAO UNIVERSITY   (China)

^b BINZHOU MEDICAL UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 8 [4 (1 AMINOCYCLOBUTYL)PHENYL] 9 PHENYL 1,2,4 TRIAZOLO[3,4 F][1,6]NAPHTHYRIDIN 3(2H) ONE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; C REACTIVE PROTEIN; CARDIAC AGENT; CASPASE 3; CREATINE KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LICOCHALCONE D; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PROTEIN KINASE B; PYRROLIDINE DITHIOCARBAMATE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CARDIOTONIC AGENT; CHALCONE DERIVATIVE;

ANIMAL TISSUE; ANTIAPOPTOSIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLIC BLOOD PRESSURE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME PHOSPHORYLATION; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; APOPTOSIS; CARDIAC MUSCLE; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; HEART FUNCTION TEST; IN VITRO STUDY; INFLAMMATION; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; PERFUSION; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; CHALCONES; GLUTATHIONE; HEART FUNCTION TESTS; IN VITRO TECHNIQUES; INFLAMMATION; MALE; MALONDIALDEHYDE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERFUSION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 84936803159     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128375     Document Type: Article

References (54)

1. Khalili H, Talasaz AH, Jenab Y, Salarifar M. Clinical characteristics and risk assessment of ST-segment elevation myocardial infarction patients of an Iranian referral center. J Cardiovasc Med (Hagerstown). 2012; 13(11):708-15. Epub 2012/08/24. doi: 10.2459/JCM.0b013e328356a3c6 PMID: 22914305.
2. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res. 2000; 47(3):446-56. Epub 2000/08/30. doi: S0008-6363(00)00078-X [pii]. PMID: 10963718.
3. Khan M, Varadharaj S, Ganesan LP, Shobha JC, Naidu MU, Parinandi NL, et al. C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling. Am J Physiol Heart Circ Physiol. 2006; 290(5):H2136-45. Epub 2005/12/24. doi: 01072.2005 [pii] doi: 10.1152/ajpheart.01072.2005 PMID: 16373583.
4. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 2008; 88(2):581-609. Epub 2008/04/09. doi: 10.1152/physrev.00024.2007 88/2/581 [pii]. PMID: 18391174; PubMed Central PMCID: PMC3199571.
5. Song L, Yang H, Wang HX, Tian C, Liu Y, Zeng XJ, et al. Inhibition of 12/15 lipoxygenase by baicalein reduces myocardial ischemia/reperfusion injury via modulation of multiple signaling pathways. Apoptosis. 2014; 19(4):567-80. Epub 2013/11/20. doi: 10.1007/s10495-013-0946-z PMID: 24248985.
6. Chen Z, Oberley TD, Ho Y, Chua CC, Siu B, Hamdy RC, et al. Overexpression of CuZnSOD in coronary vascular cells attenuates myocardial ischemia/reperfusion injury. Free radical biology & medicine. 2000; 29(7):589-96. Epub 2000/10/18. doi: S0891584900003634 [pii]. PMID: 11033410.
7. Das DK, Maulik N. Antioxidant effectiveness in ischemia-reperfusion tissue injury. Methods Enzymol. 1994; 233:601-10. Epub 1994/01/01. doi: S0076-6879(94)33063-8 [pii]. PMID: 8015492.
8. Duarte J, Perez-Palencia R, Vargas F, Ocete MA, Perez-Vizcaino F, Zarzuelo A, et al. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. British journal of pharmacology. 2001; 133(1):117-24. doi: 10.1038/sj.bjp.0704064 PMID: 11325801; PubMed Central PMCID: PMC1572775.
9. Duarte J, Perez Vizcaino F, Utrilla P, Jimenez J, Tamargo J, Zarzuelo A. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. General pharmacology. 1993; 24 (4):857-62. PMID: 8224739.
10. Duarte J, Jimenez R, Villar IC, Perez-Vizcaino F, Jimenez J, Tamargo J. Vasorelaxant effects of the bioflavonoid chrysin in isolated rat aorta. Planta medica. 2001; 67(6):567-9. doi: 10.1055/s-2001-16492 PMID: 11509985.
11. Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T. Quercetin reduces blood pressure in hypertensive subjects. The Journal of nutrition. 2007; 137(11):2405-11. PMID: 17951477.
12. Hayek T, Fuhrman B, Vaya J, Rosenblat M, Belinky P, Coleman R, et al. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arteriosclerosis, thrombosis, and vascular biology. 1997; 17(11):2744-52. PMID: 9409251.
13. Loke WM, Proudfoot JM, Hodgson JM, McKinley AJ, Hime N, Magat M, et al. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arteriosclerosis, thrombosis, and vascular biology. 2010; 30(4):749-57. doi: 10. 1161/ATVBAHA.109.199687 PMID: 20093625.
14. Perez-Vizcaino F, Duarte J. Flavonols and cardiovascular disease. Molecular aspects of medicine. 2010; 31(6):478-94. doi: 10.1016/j.mam.2010.09.002 PMID: 20837053.
15. Wright B, Spencer JP, Lovegrove JA, Gibbins JM. Insights into dietary flavonoids as molecular templates for the design of anti-platelet drugs. Cardiovascular research. 2013; 97(1):13-22. doi: 10.1093/cvr/cvs304 PMID: 23024269; PubMed Central PMCID: PMC3527766.
16. Testai L, Martelli A, Cristofaro M, Breschi MC, Calderone V. Cardioprotective effects of different flavonoids against myocardial ischaemia/reperfusion injury in Langendorff-perfused rat hearts. J Pharm Pharmacol. 2013; 65(5):750-6. Epub 2013/04/23. doi: 10.1111/jphp.12032 PMID: 23600393.
17. Yap S, Qin C, Woodman OL. Effects of resveratrol and flavonols on cardiovascular function: Physiological mechanisms. BioFactors. 2010; 36(5):350-9. doi: 10.1002/biof.111 PMID: 20803524.
18. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free radical biology & medicine. 1996; 20(7):933-56. PMID: 8743980.
19. Pietta PG. Flavonoids as antioxidants. Journal of natural products. 2000; 63(7):1035-42. PMID: 10924197.
20. Falchi M, Bertelli A, Lo Scalzo R, Morassut M, Morelli R, Das S, et al. Comparison of cardioprotective abilities between the flesh and skin of grapes. Journal of agricultural and food chemistry. 2006; 54 (18):6613-22. doi: 10.1021/jf061048k PMID: 16939317.
21. Dong L, Fan Y, Shao X, Chen Z. Vitexin protects against myocardial ischemia/reperfusion injury in Langendorff-perfused rat hearts by attenuating inflammatory response and apoptosis. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association. 2011; 49(12):3211-6. doi: 10.1016/j.fct.2011.09.040 PMID: 22001368.
22. Lu N, Sun Y, Zheng X. Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition. Planta medica. 2011; 77(10):984-91. doi: 10.1055/s-0030-1250718 PMID: 21283956.
23. Fang F, Li D, Pan H, Chen D, Qi L, Zhang R, et al. Luteolin inhibits apoptosis and improves cardiomyocyte contractile function through the PI3K/Akt pathway in simulated ischemia/reperfusion. Pharmacology. 2011; 88(3-4):149-58. doi: 10.1159/000330068 PMID: 21934351.
24. Guler A, Sahin MA, Yucel O, Yokusoglu M, Gamsizkan M, Ozal E, et al. Proanthocyanidin prevents myocardial ischemic injury in adult rats. Medical science monitor: international medical journal of experimental and clinical research. 2011; 17(11):BR326-31. PMID: 22037735; PubMed Central PMCID: PMC3539496.
25. Thomas CJ, Ng DC, Patsikatheodorou N, Limengka Y, Lee MW, Darby IA, et al. Cardioprotection from ischaemia-reperfusion injury by a novel flavonol that reduces activation of p38 MAPK. European journal of pharmacology. 2011; 658(2-3):160-7. doi: 10.1016/j.ejphar.2011.02.041 PMID: 21371449.
26. Pogula BK, Maharajan MK, Oddepalli DR, Boini L, Arella M, Sabarimuthu DQ. Morin protects heart from beta-adrenergic-stimulated myocardial infarction: an electrocardiographic, biochemical, and histological study in rats. Journal of physiology and biochemistry. 2012; 68(3):433-46. doi: 10.1007/s13105-012-0157-z PMID: 22419268.
27. Arumugam S, Thandavarayan RA, Arozal W, Sari FR, Giridharan VV, Soetikno V, et al. Quercetin offers cardioprotection against progression of experimental autoimmune myocarditis by suppression of oxidative and endoplasmic reticulum stress via endothelin-1/MAPK signalling. Free radical research. 2012;46(2):154-63. doi: 10.3109/10715762.2011.647010 PMID: 22145946.
28. Haraguchi H, Ishikawa H, Mizutani K, Tamura Y, Kinoshita T. Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorganic & medicinal chemistry. 1998; 6(3):339-47. PMID: 9568287.
29. Park HG, Bak EJ, Woo GH, Kim JM, Quan Z, Yoon HK, et al. Licochalcone E has an antidiabetic effect. J Nutr Biochem. 2012; 23(7):759-67. Epub 2011/08/16. doi: 10.1016/j.jnutbio.2011.03.021 S0955-2863(11)00125-2 [pii]. PMID: 21840191.
30. Kim SJ, Kim CG, Yun SR, Kim JK, Jun JG. Synthesis of licochalcone analogues with increased anti-inflammatory activity. Bioorganic & medicinal chemistry letters. 2014; 24(1):181-5. doi: 10.1016/j.bmcl.2013.11.044 PMID: 24316124.
31. Tanifuji S, Aizu-Yokota E, Funakoshi-Tago M, Sonoda Y, Inoue H, Kasahara T. Licochalcones suppress degranulation by decreasing the intracellular Ca2+ level and tyrosine phosphorylation of ERK in RBL-2H3 cells. Int Immunopharmacol. 2010; 10(7):769-76. Epub 2010/04/20. doi: 10.1016/j.intimp. 2010.04.007 S1567-5769(10)00121-9 [pii]. PMID: 20399908.
32. Furusawa J, Funakoshi-Tago M, Mashino T, Tago K, Inoue H, Sonoda Y, et al. Glycyrrhiza inflata-derived chalcones, Licochalcone A, Licochalcone B and Licochalcone D, inhibit phosphorylation of NFkappaB p65 in LPS signaling pathway. International immunopharmacology. 2009; 9(4):499-507. PMID: 19291859.
33. Huang C, Liu W, Perry CN, Yitzhaki S, Lee Y, Yuan H, et al. Autophagy and protein kinase C are required for cardioprotection by sulfaphenazole. Am J Physiol Heart Circ Physiol. 2010; 298(2):H570-9. Epub 2009/12/17. doi: 10.1152/ajpheart.00716.2009 00716.2009 [pii]. PMID: 20008275; PubMed Central PMCID: PMC2822573.
34. Shen M, Wu RX, Zhao L, Li J, Guo HT, Fan R, et al. Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism. PloS one. 2012; 7(12):e51223. Epub 2013/01/04. doi: 10.1371/journal.pone.0051223 PONE-D-12-21963 [pii]. PMID: 23284668; PubMed Central PMCID: PMC3527482.
35. Lagneux C, Joyeux M, Demenge P, Ribuot C, Godin-Ribuot D. Protective effects of melatonin against ischemia-reperfusion injury in the isolated rat heart. Life Sci. 2000; 66(6):503-9. Epub 2000/05/04. doi: S0024320599006207 [pii]. PMID: 10794067.
36. Ding HL, Zhu HF, Dong JW, Zhu WZ, Yang WW, Yang HT, et al. Inducible nitric oxide synthase contributes to intermittent hypoxia against ischemia/reperfusion injury. Acta Pharmacol Sin. 2005; 26(3):315-22. Epub 2005/02/18. doi: 10.1111/j.1745-7254.2005.00046.x PMID: 15715927.
37. Han J, Wang D, Yu B, Wang Y, Ren H, Zhang B, et al. Cardioprotection against ischemia/reperfusion by licochalcone B in isolated rat hearts. Oxid Med Cell Longev. 2014; 2014:134862. Epub 2014/09/13. doi: 10.1155/2014/134862 PMID: 25215172; PubMed Central PMCID: PMC4158311.
38. Bowden RA, Ding ZM, Donnachie EM, Petersen TK, Michael LH, Ballantyne CM, et al. Role of alpha4 integrin and VCAM-1 in CD18-independent neutrophil migration across mouse cardiac endothelium. Circ Res. 2002; 90(5):562-9. Epub 2002/03/23. PMID: 11909820.
39. Feng Y, Zhao H, Xu X, Buys ES, Raher MJ, Bopassa JC, et al. Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice. Am J Physiol Heart Circ Physiol. 2008; 295(3):H1311-H8. Epub 2008/07/29. doi: 10.1152/ajpheart.00119.200800119.2008 [pii]. PMID: 18660455; PubMed Central PMCID: PMC2544501.
40. Kleikers PW, Wingler K, Hermans JJ, Diebold I, Altenhofer S, Radermacher KA, et al. NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury. J Mol Med (Berl). 2012; 90(12):1391-406. Epub 2012/10/24. doi: 10.1007/s00109-012-0963-3 PMID: 23090009.
41. Matsushima S, Kuroda J, Ago T, Zhai P, Ikeda Y, Oka S, et al. Broad suppression of NADPH oxidase activity exacerbates ischemia/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1alpha and upregulation of peroxisome proliferator-activated receptor-alpha. Circ Res. 2013; 112(8):1135-49. Epub 2013/03/12. doi: 10.1161/CIRCRESAHA.111.300171 CIRCRESAHA.111.300171 [pii]. PMID: 23476056.
42. Wan LL, Xia J, Ye D, Liu J, Chen J, Wang G. Effects of quercetin on gene and protein expression of NOX and NOS after myocardial ischemia and reperfusion in rabbit. Cardiovasc Ther. 2009; 27(1):28-33. Epub 2009/02/12. doi: 10.1111/j.1755-5922.2009.00071.x CDR071 [pii]. PMID: 19207477.
43. Jeddi S, Zaman J, Ghasemi A. Effects of ischemic postconditioning on the hemodynamic parameters and heart nitric oxide levels of hypothyroid rats. Arq Bras Cardiol. 2015; 104(2):136-43. Epub 2014/11/27. doi: 10.5935/abc.20140181 S0066-782X2014005040181 [pii]. PMID: 25424164; PubMed Central PMCID: PMC4375657.
44. Ferdinandy P, Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol. 2003; 138(4):532-43. Epub 2003/02/25. doi: 10.1038/sj.bjp.0705080 PMID: 12598407; PubMed Central PMCID: PMC1573696.
45. Wang XL, Liu HR, Tao L, Liang F, Yan L, Zhao RR, et al. Role of iNOS-derived reactive nitrogen species and resultant nitrative stress in leukocytes-induced cardiomyocyte apoptosis after myocardial ischemia/reperfusion. Apoptosis. 2007; 12(7):1209-17. Epub 2007/03/03. doi: 10.1007/s10495-007-0055-y PMID: 17333318.
46. Ji L, Fu F, Zhang L, Liu W, Cai X, Zheng Q, et al. Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. American journal of physiology Endocrinology and metabolism. 2010; 298(4):E871-80. Epub 2010/02/04. doi: 10.1152/ajpendo.00623.2009 ajpendo.00623.2009 [pii]. PMID: 20124508.
47. Liang F, Gao E, Tao L, Liu H, Qu Y, Christopher TA, et al. Critical timing of L-arginine treatment in postischemic myocardial apoptosis-role of NOS isoforms. Cardiovasc Res. 2004; 62(3):568-77. Epub 2004/05/26. doi: 10.1016/j.cardiores.2004.01.025 S0008636304000513 [pii]. PMID: 15158149.
48. Yin Y, Guan Y, Duan J, Wei G, Zhu Y, Quan W, et al. Cardioprotective effect of Danshensu against myocardial ischemia/reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation. Eur J Pharmacol. 2013; 699(1-3):219-26. Epub 2012/12/04. doi: 10.1016/j. ejphar.2012.11.005 S0014-2999(12)00936-3 [pii]. PMID: 23200898.
49. Zhang T, Yang D, Fan Y, Xie P, Li H. Epigallocatechin-3-gallate enhances ischemia/reperfusion-induced apoptosis in human umbilical vein endothelial cells via AKT and MAPK pathways. Apoptosis. 2009; 14(10):1245-54. Epub 2009/08/12. doi: 10.1007/s10495-009-0391-1 PMID: 19669889.
50. Baines CP, Molkentin JD. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol. 2005; 38(1):47-62. Epub 2004/12/30. doi: S0022-2828(04)00325-6 [pii] doi: 10.1016/j.yjmcc.2004.11.004 PMID: 15623421.
51. Lim NR, Thomas CJ, Silva LS, Yeap YY, Yap S, Bell JR, et al. Cardioprotective 3′,4′-dihydroxyflavonol attenuation of JNK and p38(MAPK) signalling involves CaMKII inhibition. Biochem J. 2013; 456 (2):149-61. Epub 2013/09/17. doi: 10.1042/BJ20121538 BJ20121538 [pii]. PMID: 24032640.
52. Kim SJ, Li M, Jeong CW, Bae HB, Kwak SH, Lee SH, et al. Epigallocatechin-3-gallate, a green tea catechin, protects the heart against regional ischemia-reperfusion injuries through activation of RISK survival pathways in rats. Arch Pharm Res. 2014; 37(8):1079-85. Epub 2013/12/07. doi: 10.1007/s12272-013-0309-x PMID: 24307060.
53. Wang M, Baker L, Tsai BM, Meldrum KK, Meldrum DR. Sex differences in the myocardial inflammatory response to ischemia-reperfusion injury. American journal of physiology Endocrinology and metabolism. 2005; 288(2):E321-6. Epub 2004/09/16. doi: 10.1152/ajpendo.00278.2004 00278.2004 [pii]. PMID: 15367393.
54. Armstrong SC. Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res. 2004; 61(3):427-36. Epub 2004/02/14. doi: 10.1016/j.cardiores.2003.09.031 S000863630300662X [pii]. PMID: 14962474.